| Announce Date | 10/31/2025 |
| EPS Normalized Actual | $0.91 (Beat by $0.03) |
| EPS GAAP Actual | $0.91 (Beat by $0.03) |
| Revenue Actual | $1.054B |
| Revenue Surprise | Beat by $1054M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.94575 |
| EPS GAAP Estimate | $0.94575 |
| Revenue Estimate | $0.957215811B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Dec 2027 | 4.12 | 25.95 | 4.07594 | 4.20733 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.75 | -0.14893 | 1.054B | 25.81% | 115.83M |
| FQ2 2025 (Jun 2025) | 0.68 | -0.22392 | 0.9631B | 8.6% | 28.84M |
| FQ1 2025 (Mar 2025) | 2.18 | 1.37508 | 0.8093B | -8.07% | -101.69M |
| FQ4 2024 (Dec 2024) | 0.0649 | 0.0649 | 0.7522B | -14.49% | 752.2M |
| FQ3 2024 (Sep 2024) | 0.63 | 0.63 | 0.782B | -9.82% | 782M |
| FQ4 2016 (Dec 2016) | 0 | 0 | 0.5077B | 100% | 507.7M |
| FQ2 2024 (Jun 2024) | 0.67 | 0.67 | 0.8803B | 8.78% | 880.3M |
| FQ1 2024 (Mar 2024) | 0.64 | 0.64 | 0.8746B | 15.32% | 874.6M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.94575
Consensus Revenue Estimates
0.957215811B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.01965 | -- | 1.005 | 1.03814 | 4 |
| FQ3 2027 (Sep 2027) | 0.98002 | -- | 0.95165 | 1.00256 | 1 |
| FQ2 2027 (Jun 2027) | 0.98745 | -- | 0.95886 | 1.01016 | 1 |
| FQ1 2027 (Mar 2027) | 0.87217 | -- | 0.85377 | 0.88454 | 2 |
| FQ4 2026 (Dec 2026) | 0.76 | -- | 0.75065 | 0.76492 | 1 |
| FQ3 2026 (Sep 2026) | 0.82 | 8.54 | 0.80991 | 0.82531 | 1 |
| FQ2 2026 (Jun 2026) | 0.87 | 21.84 | 0.85929 | 0.87564 | 1 |
| FQ1 2026 (Mar 2026) | 0.77 | -183.12 | 0.76052 | 0.77499 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.12B | -- | 1.11B | 1.14B | 5 |
| FQ3 2027 (Sep 2027) | 0.93B | -- | 0.91B | 0.95B | 2 |
| FQ2 2027 (Jun 2027) | 0.92B | -- | 0.9B | 0.93B | 2 |
| FQ1 2027 (Mar 2027) | 0.88B | -- | 0.87B | 0.89B | 2 |
| FQ4 2026 (Dec 2026) | 0.86B | -- | 0.86B | 0.87B | 1 |
| FQ3 2026 (Sep 2026) | 0.87B | -21.07 | 0.86B | 0.87B | 1 |
| FQ2 2026 (Jun 2026) | 0.89B | -8.82 | 0.88B | 0.89B | 1 |
| FQ1 2026 (Mar 2026) | 0.87B | 7.03 | 0.86B | 0.87B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.89893 | 0.75 | -0.14893 | -19.86% |
| FQ2 2025 (Jun 2025) | 0.90392 | 0.68 | -0.22392 | -32.93% |
| FQ1 2025 (Mar 2025) | 0.80492 | 2.18 | 1.37508 | 63.08% |
| FQ4 2024 (Dec 2024) | 0.0649 | 0.0649 | 100% | |
| FQ3 2024 (Sep 2024) | 0.63 | 0.63 | 100% | |
| FQ4 2016 (Dec 2016) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.67 | 0.67 | 100% | |
| FQ1 2024 (Mar 2024) | 0.64 | 0.64 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.94B | $1.05B | $115.83M | 10.99% |
| FQ2 2025 (Jun 2025) | $0.93B | $0.96B | $28.84M | 2.99% |
| FQ1 2025 (Mar 2025) | $0.91B | $0.81B | $-101.69M | -12.57% |
| FQ4 2024 (Dec 2024) | $0B | $0.75B | $752.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.78B | $782M | 100% |
| FQ4 2016 (Dec 2016) | $0B | $0.51B | $507.7M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.88B | $880.3M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.87B | $874.6M | 100% |